[HTML][HTML] COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study

R Derwand, M Scholz, V Zelenko - International journal of antimicrobial …, 2020 - Elsevier
The aim of this study was to describe the outcomes of patients with coronavirus disease
2019 (COVID-19) in the outpatient setting after early treatment with zinc, low-dose …

[PDF][PDF] COVID-19 outpatients–early risk-stratified treatment with zinc plus low dose hydroxychloroquine and azithromycin: a retrospective case series study

R Derwand, M Scholz, V Zelenko - jeffreydachmd.com
Objective: To describe outcomes of patients with coronavirus disease 2019 (COVID-19) in
the outpatient setting after early treatment with zinc, low dose hydroxychloroquine, and …

[HTML][HTML] COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study

R Derwand, M Scholz, V Zelenko - International Journal of …, 2020 - ncbi.nlm.nih.gov
The aim of this study was to describe the outcomes of patients with coronavirus disease
2019 (COVID-19) in the outpatient setting after early treatment with zinc, low-dose …

[PDF][PDF] COVID-19 outpatients–early risk-stratified treatment with zinc plus low dose hydroxychloroquine and azithromycin: a retrospective case series study

R Derwand, M Scholz, V Zelenko - ulmo.us
Objective: To describe outcomes of patients with coronavirus disease 2019 (COVID-19) in
the outpatient setting after early treatment with zinc, low dose hydroxychloroquine, and …

[PDF][PDF] COVID-19 outpatients–early risk-stratified treatment with zinc plus low dose hydroxychloroquine and azithromycin: a retrospective case series study

R Derwand, M Scholz, V Zelenko - voorwaarheid.nl
Objective: To describe outcomes of patients with coronavirus disease 2019 (COVID-19) in
the outpatient setting after early treatment with zinc, low dose hydroxychloroquine, and …

[引用][C] COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study

R Derwand, M Scholz, V Zelenko - International Journal of Antimicrobial …, 2020 - cir.nii.ac.jp
COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine
and azithromycin: a retrospective case series study | CiNii Research CiNii 国立情報学研究所 …

[PDF][PDF] COVID-19 outpatients–early risk-stratified treatment with zinc plus low dose hydroxychloroquine and azithromycin: a retrospective case series study

R Derwand, M Scholz, V Zelenko - thewebmatrix.net
Objective: To describe outcomes of patients with coronavirus disease 2019 (COVID-19) in
the outpatient setting after early treatment with zinc, low dose hydroxychloroquine, and …

COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study

R Derwand, M Scholz… - International journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
The aim of this study was to describe the outcomes of patients with coronavirus disease
2019 (COVID-19) in the outpatient setting after early treatment with zinc, low-dose …

[PDF][PDF] COVID-19 outpatients–early risk-stratified treatment with zinc plus low dose hydroxychloroquine and azithromycin: a retrospective case series study

R Derwand, M Scholz, V Zelenko - breggin.com
Objective: To describe outcomes of patients with coronavirus disease 2019 (COVID-19) in
the outpatient setting after early treatment with zinc, low dose hydroxychloroquine, and …

[PDF][PDF] COVID-19 Outpatients–Early Risk-Stratified Treatment with Zinc Plus Low Dose Hydroxychloroquine and Azithromycin: A Retrospective Case Series Study

R Derwand, M Scholz, V Zelenko - 2020 - academia.edu
Objective: To describe outcomes of patients with coronavirus disease 2019 (COVID-19) in
the outpatient setting after early treatment with zinc, low dose hydroxychloroquine, and …